PrEP Generics Soon to be Available: FAQs
An FAQ document developed by National Alliance of State and Territorial AIDS Directors (NASTAD) that provides current information on the introduction of PrEP generics, potential coverage changes related to the changing PrEP drug market, and the impact on PrEP access.
Source:
NASTAD
Audience:
Navigation Staff
Topic:
PrEP Initiation, Insurance, and Reimbursement